3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
4
Thoracic
3
Head & Neck
2
Gynecologic
1
CNS
1
Conditions
Brain Neoplasms
264
Glioblastoma
193
Glioma
159
Neuroblastoma
56
Central Nervous System Neoplasms
55
Astrocytoma
45
Carcinoma, Non-Small-Cell Lung
39
Neoplasms
32
Breast Neoplasms
27
Oligodendroglioma
26
Meningioma
23
Recurrence
21
Neuroma, Acoustic
21
Neoplasm Metastasis
20
Meningeal Carcinomatosis
20
Gliosarcoma
20
Neurofibromatosis 1
18
Medulloblastoma
18
Lung Neoplasms
15
Paraganglioma
14
Lymphoma
14
Pheochromocytoma
13
Spinal Cord Neoplasms
12
Sarcoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Burkitt Lymphoma
9
Pancreatic Neoplasms
8
Ovarian Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
CNS
×
Clear all
NCT05235737
2023-08-31
PIRG
Medical University of Silesia
Phase 4
Unknown
36 enrolled